In the Grafenegg Auditorium, the renowned ...
Lenvatinib is a since 2018 approved drug for ...
The results of the MISSCARE Austria study by Karl ...
Lots of public interest at the stand of the ...
As early as 2018, a research team of the MedUni ...
Pia Gattinger, from MedUni Vienna's Centre ...
Pilot operation of the project started in ...
For the first time, type, cause and outcome ...
Plant-derived ring peptide and its variants show ...